Woodburn Management Ii Ltd investment portfolio

Cydar Medical creates regulated cloud‑based AI and data‑fusion software that supports image‑guided, minimally invasive endovascular surgery, helping healthcare organisations improve surgical planning, accuracy and patient outcomes.

Sphere Bio develops and supplies microfluidic instruments, consumables and assay kits for single‑cell screening, cell line development, antibody discovery, cell therapy engineering and synthetic biology, targeting biopharmaceutical researchers and developers. It operates as a brand of Fluidic Sciences Ltd following the acquisition of its business and assets in September 2025.